StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) a catalyst driven idea at Morgan Stanley
January 6, 2023 12:17 PM
Morgan Stanley analyst Matthew Harrison labeled Moderna (NASDAQ: MRNA) a Catalyst Driven Idea in a note Friday, maintaining an Equal-Weight ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot List
Next Articles
After-hours movers: CytomX jumps on Moderna deal, WWE gains as McMahon supports possible sale
January 5, 2023 5:42 PM
Morgan Stanley Calls Moderna (MRNA) a Catalyst Driven Idea
January 5, 2023 4:09 PM
Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
January 5, 2023 4:06 PM
Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
January 5, 2023 4:06 PM
CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
January 5, 2023 4:05 PM
Moderna (MRNA) PT Raised to $195 at BofA Securities
January 4, 2023 10:24 AM
